Clinical Trial Update: Rituximab Plus CHOP With Sargramostim in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating rituximab plus CHOP with sargramostim in newly diagnosed diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• CHOP (cyclophosphamide, doxorubicin, vincristine, prednisone)
• Rituximab (rituximab)
• sargramostim (sargramostim)

Snippet

Sponsor: University of Southern California | Conditions: Diffuse, Large B-Cell, Lymphoma | Phase 2 | Status: COMPLETED